The over-expression of TIPE2 significantly lowered the proliferation of macrophages and inhibited the secretion of pro-inflammatory factors, becoming a new anti-inflammatory therapy to alleviate muscle weakness in patients with muscular dystrophy [30]. The gene discussed is TIPE2; the disease is muscular dystrophy.